In addition to EMT inhibition, HDAC inhibitors may exert pleiotropic effects on cancer cell death, cell differentiation, angiogenesis, cell cycle, and immune modulation in lung cancer [13, 14]. The gene discussed is HDAC9; the disease is lung carcinoma.